MACHINES

Real Time PCR

Rotor Gene-Q (QIAGEN)

Whether your passion for answers takes you to a laboratory bench or a hospital bedside, the pursuit often begins with a blood or tissue sample. The deepest mysteries of disease and other biological processes – the answers you seek – are encoded in the building blocks of life, DNA.

Yet the work of learning what these molecules can tell you is quite a journey, and we at QIAGEN understand the challenges associated with this quest.

Our commitment is to enable you, like more than 500,000 customers around the world, to quickly and reliably reach your goal of useful, actionable insights. To this end, QIAGEN offers you innovative solutions that cover every single step along this journey – not just technologies, but bridges from samples to insights. As you advance to new frontiers, QIAGEN also advances – and this website’s updated look and feel reflects our end-to-end commitment to your journey.

Sample to Insight means QIAGEN offers you the industry’s most reliable sample technologies, because samples matter to your success. Our top-quality assays and panels enable you to accurately analyze and identify diseases and genetic variations. Our bioinformatics software and curated knowledge bases transform your raw data into relevant, actionable findings. And our automation solutions provide you seamless and cost-effective workflows. Sample to Insight.

The insights you gain may lead to one small step or a giant leap forward for science and healthcare. Partnering with QIAGEN, your work can make a difference!

For outstanding performance in real-time PCR

Outstanding thermal and optical performance due to rotary format
An unmatched optical range spanning UV to infrared wavelengths
State-of-the art analyses supported by user-friendly software
Low maintenance and maximum convenience due to robust design
High performance in multiple applications with QIAGEN assays

QIAGEN's real-time PCR cycler, the Rotor-Gene Q, combines multiple optimized design features to provide the outstanding performance and reliable results that your research demands. Together with optimized QIAGEN kits for real-time PCR, the Rotor-Gene Q enables streamlined analysis for a wide range of applications.

Real Time PCR

MiniOpticon (BIORAD)

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 7,750 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.

Life Science Research
Bio-Rad's Life Science Group develops, manufactures, and markets a wide range of laboratory instruments, apparatus, and consumables used for research in functional genomics, proteomics, and food safety. The group ranks among the top five life science companies worldwide, and maintains a solid reputation for quality, innovation, and a longstanding focus on the success of its customers. Bio-Rad's life science products are based on technologies used to separate, purify, identify, analyze, and amplify biological materials such as proteins, nucleic acids, and bacteria. These technologies include electrophoresis, imaging, multiplex immunoassay, chromatography, microbiology, bioinformatics, protein function analysis, transfection, amplification, real-time and droplet digital PCR. Bio-Rad products support researchers in laboratories throughout the world

Clinical Diagnostics
The Clinical Diagnostics Group develops, manufactures, sells, and supports a large portfolio of products for laboratory diagnostics. Bio-Rad is a leading specialty diagnostics company and its products are recognized as the gold standard for diabetes monitoring and quality control (QC) systems. The company is also well known for its blood virus testing and detection, blood typing, and autoimmune and genetic disorders testing. Bio-Rad's clinical diagnostics products incorporate a broad range of technologies used to detect, identify, and quantify substances in bodily fluids and tissues. The results are used as aids to support medical diagnosis, detection, evaluation, and the monitoring and treatment of diseases and other medical conditions

The MiniOpticon™ system is a compact, two-color, real-time detection platform built on the MJ Mini™ cycler. It is one of the smallest and most portable systems available for real-time PCR applications and gel-free PCR analysis. Its two-color multiplexing capability allows detection of a range of fluorophores.

In the MiniOpticon system, samples are sequentially illuminated by a fixed array of 48 light-emitting diodes (LEDs), minimizing cross talk. Emitted fluorescence is detected by one of two filtered photodiodes to ensure independent detection of both colors.

This no-moving-parts design allows sensitive detection in a small but robust package. The MiniOpticon system incorporates all the features of the MJ Mini cycler, including precise thermal control and temperature gradient capability.

Real Time PCR

SmartCycler® PCR Systems, Cepheid®

Mr. Bishop joined Cepheid as Chief Executive Officer and as a director in April 2002, and became Chairman of the Board of Directors in February 2013. From 1993 to 2002, Mr. Bishop served as President, later President and Chief Executive Officer, and a director of Vysis, Inc., a genomic disease management company that was acquired by Abbott. From 1991 until 1993, Mr. Bishop was Chairman and Chief Executive Officer of MicroProbe Corporation, a biotechnology company, and, from 1987 until 1991, of Source Scientific Systems, a biomedical instrument manufacturing company. Prior to that, from 1984 to 1986, Mr. Bishop was President and Chief Operating Officer of Gen-Probe, Inc. Before joining Gen-Probe, Mr. Bishop held various management positions between 1968 and 1984 at American Hospital Supply Company and its affiliates, including a three-year assignment in Japan as Executive Vice President and Chief Executive Officer of International Reagents Corp., a joint venture between American Hospital Supply Company and Green Cross Corporation. Mr. Bishop served as a director of Conceptus from February 2009 until June 2013 when it was acquired by the Bayer Group. He has been a member of the AdvaMed Dx Board, since 2010, and was elected Chairman in December 2013. Additionally, Mr. Bishop has served as a director of Veracyte, Inc., since November 2014. In 2011, Mr. Bishop received the Ernst & Young Entrepreneur Of The Year® Northern California Award in the Life Sciences category.

Each of these random-access, real-time, modular PCR processing units can test 16 different protocols simultaneously. Up to six units can be connected into one system allowing 96 different protocols to be run at once. Every site of the unit is calibrated optically and thermally to perform the same when programmed to run identical protocols. Systems can optimize PCR denaturation, annealing and extension temperatures, and times in a single run. Average time to results is 20–40 minutes, less than half the time of a 96-well plate instrument. Two SmartCycler® units can process an equal or greater number of samples per day than a 96-well instrument. Previous runs can be viewed and analyzed, and results can be printed while the unit is still in use. A new run can always be created and started while other runs are still in progress.

Immunoassay

Access-2 (Beckman Coulter)

Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. For more than 75 years, our products have been making a difference in peoples' lives by improving the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery.

Beckman Coulter serves customers in two segments: Diagnostics and Life Sciences.
✔Our diagnostics customers include hospitals and laboratories around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients.
✔Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs.
✔As part of Life Sciences, the Particle Characterization and Counting business serves biopharma production and QC environments, as well as research functions within large biopharma companies.

A Lab Forward Design, to Fit Your Space and Time.

The Access 2 was designed to have the robustness of a reference-lab immunoassay analyzer in the convenient size of a bench-top instrument; giving you greater control over quality, reliability and speed without sacrificing valuable floor space.

The Access 2 delivers an extensive immunoassay diagnostic-testing menu that includes sTfR in our anemia panel as well as SHBG and Testosterone in our comprehensive reproductive panel.

Immunoassay

AIA-600 (Tosoh Biosciences)

Tosoh Bioscience has throughout the years demonstrated Technological Leadership in a number of Diagnostics niche markets including Immunochemistry, HPLC based diabetes and thalassemia screening and Molecular Biology.

This leadership is based on an in-depth understanding of the ever growing clinical demand for faster and more precise diagnosis of a number of life threatening pathologies (e.g. tumour, cardiac, diabetes etc).

It is also based on the analysis of operational requirements emanating from laboratories worldwide, where quality of results, be it essential, is just not good enough anymore.

Just a few examples of how Tosoh Bioscience reconciles quality of results and workflow optimisation include:

Standardisation across platforms with a unitary dry chemistry reagent concept;
Workload management through flexible capacity loading options;
Connections to most automated production units;
Extended calibration stability;
One of the industry’s best ‘up-time’ performance for our analysers.

Bench top Immunoassay Analyser

Offers the automation powers and performance of a large analyser in a bench top format. Random access allows any combination of tests, in any order at any time and a throughput of 36 results per hour with the first result in 20 minutes ensures a fast reliable service.

Will accept a variety of primary tubes with positive patient identification as well as positive test cup ID to eliminate errors.
Sample level sensing, to alert operator to short samples
Dual clot detection to maintain result integrity
Extremely simple operation
Unidirectional interface
Just 40 x 40 x 50cm and 30kg
Results are consistent and interchangeable between other Tosoh AIA analysers

The touchscreen, intuitive menus and onboard 'wizards' make the AIA-360 our easiest to use analyser to date.

Hematology

Nehan Kohden

Nihon Kohden is Japan's leading manufacturer, developer and distributor of medical electronic equipment with subsidiaries in the USA, Europe and Asia and distributors in nearly every country in the world.

Our major product lines for export are patient monitors, electroencephalographs, evoked potential and electromyograph systems, electrocardiographs, defibrillators, and hematology analyzers. Nihon Kohden equipment is well known for its quality and ease of use.

Nihon Kohden actively contributes to the advance of medical technology. Nihon Kohden researchers have published valuable research in some of the world's most prestigious medical, engineering and scientific journals. Nihon Kohden has significantly contributed to the advancement of modern medical treatment with many innovative products and technologies. Pulse oximetry, the technology to noninvasive measure oxygen in the blood, was invented by Dr. Takuo Aoyagi, a Nihon Kohden scientist.

In addition to supplying the world with our own high quality medical equipment, Nihon Kohden imports outstanding overseas products into Japan. Our wide range of imported equipment includes cardiology, urology, respiratory care, anesthesiology, emergency care, sports medicine and rehabilitation. Our extensive domestic sales network consists of over 650 direct sales staff with over 100 offices throughout the country.

Founded in 1951, our mission is to improve the quality of life through advanced medical technology.

Automatic analyzer with 19 parameters and WBC 3 part diff.

Chemistry Analyzer

ACE Alera® Clinical Chemistry System

The ACE Alera system is the proven, high-performance, low-maintenance chemistry analyzer capable of improving patient care and your bottom line.

The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of a bench-top model.

Chemistry Analyzer

Microlab 300 (ELITechGroup)

The ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITechGroup has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient.

The ELITechGroup manufactures and distributes diagnostic products for clinical chemistry, microbiology, immunology, and molecular biology though direct sales and a distribution network encompassing more than 100 countries.

The Microlab 300 is a true semi-automated clinical chemistry analyzer in all its glory. A system that is designed as a clinical chemistry analyzer and not as a standard photometer. Thousands of users have experienced the proven reliability and high performance of the Microlab all over the world. Robust, compact and easy-to-use, it is ideal for smaller or satellite laboratory locations. Together with a superior menu of ready-to-use, liquid-stable reagents, the Microlab 300 covers primary, STAT or back-up testing needs. This system offers minimal maintenance and effective use of consumables to provide a truly cost effective operation.

Chemistry Analyzer

Metro Lab

For more than 25 years, UV-Vis Metrolab S.A., has designed, manufactured and marketed semi-automatic and automatic random analyzers for:

Clinical Chemistry
Analytical Chemistry
Elisa
Electrolytes
Immunoturbidimetry
Coagulation

used in medical, veterinary, industrial and research laboratories.

The instruments are marketed under Metrolab trade mark through distributors and in OEM conditions.

A professional team of experts in micromechanics, optics, fluids, electronics, software and quality control works in conjunction for developing and manufacturing excellent instruments at very competitive prices.

Metrolab warrants the quality of its products through a Quality System under the ISO 9001 and ISO 13485 Standards.

Also, most of their instruments are certified and bear CE marking.

Semi automated clinical analyzer. Graphic display and thermal printer. End point. Kinetics. Coagulation. Inmunoturbidimetry. Lineal and non lineal methods. Cut-off. Quality control. Dual holder with installed thermostated flow microcell and cuvette holder for standard and semi-micro cuvettes

Optical system
- Principle: monochromator with interferential filters
- Wavelength range: 340 - 1000nm
- Wavelength selection: automatic 9 positions filter wheel, 7 installed filters, 2 empty positions
- Factory mounted filters: 340, 405, 450, 505, 550, 620 and 750 nm
- Bandwidth: 10 +/- 2 nm
- Photometric range: -0.5 to 4.000 Abs
- Precision: +/- 0.002 Abs
- Linearity: better than +/_ 1.5 % from 0 to 1.500 Abs
- Light source: halogen lamp
- Zero: automatic
- Reading: monochromatic and bichromatic